Cargando…

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation

Background. Polycystic ovarian syndrome (PCOS) women undergoing in vitro fertilization and embryo transfer (IVF-ET) treatment always attain a low cumulative pregnancy rate disaccording with the satisfactory number of oocytes. Objective. We aim to evaluate the status of coagulation and fibrinolytic s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ying, Zhao, Yong, Yan, Ling, Chuai, Yun-Hai, Liu, Ling-Ling, Chen, Yi, Li, Min, Wang, Ai-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211182/ https://www.ncbi.nlm.nih.gov/pubmed/25374601 http://dx.doi.org/10.1155/2014/731498

Ejemplares similares

Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017)

Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome
por: Li, Shuai, et al.
Publicado: (2021)

The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
por: Pritts, Elizabeth A., et al.
Publicado: (2011)

Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
por: Izhar, Rubina, et al.
Publicado: (2021)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

GDF9 polymorphisms: influence on ovarian response in women undergoing controlled ovarian hyperstimulation
por: Bilibio, João Paolo, et al.
Publicado: (2020)

A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
por: Zhu, Xiuxian, et al.
Publicado: (2016)

Does hysteroscopic resection of polyps require cycle cancellation in women undergoing controlled ovarian hyperstimulation in the ICSI cycle?
por: Oral, Serkan
Publicado: (2022)

Pregnancy Rate after Controlled Ovarian Hyperstimulation and Intrauterine Insemination for the Treatment of Endometriosis following Surgery
por: Keresztúri, Attila, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Acupuncture for “poor ovarian response” of women to controlled ovarian hyperstimulation: A protocol for meta-analysis and systematic review
por: Wei, Wei, et al.
Publicado: (2020)

Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III–IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2020)

A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients
por: Wu, Lan, et al.
Publicado: (2017)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Alterations in follicular fluid BMP-15 RNA expression in women undergoing controlled ovarian hyperstimulation
por: DEVECİ, Şükriye Derya
Publicado: (2020)

Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles
por: Madrazo, Ivan, et al.
Publicado: (2020)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome
por: Li, Fei, et al.
Publicado: (2021)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

Persistent megalocystic ovaries after ovarian hyperstimulation syndrome in a postpartum patient with polycystic ovarian syndrome: a case report
por: Shi, Jinghua, et al.
Publicado: (2018)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

The usefulness of metaphase I oocytes in women who undergo controlled ovarian hyperstimulation for intracytoplasmic sperm injection
por: Bilibio, João Paolo, et al.
Publicado: (2021)

Spontaneous ovarian hyperstimulation syndrome: Report of two cases
por: Gui, Juan, et al.
Publicado: (2019)

Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues
por: Park, So Yun, et al.
Publicado: (2021)

Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
por: Gurbuz, Ali Sami, et al.
Publicado: (2016)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

The effect of controlled ovarian hyperstimulation on ovarian reserve via PTEN pathway
por: Sezginer, Perihan, et al.
Publicado: (2022)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Zika virus during controlled ovarian hyperstimulation
por: Joob, Beuy, et al.
Publicado: (2019)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ckfsf6fbuseuk2fbkq84js5qkc